Danaher (DHR) | Financial Analysis & Statements
Danaher Corporation Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
6.8B
Gross Profit
4.0B
58.00%
Operating Income
1.5B
21.97%
Net Income
1.2B
17.51%
EPS (Diluted)
$1.68
Balance Sheet Metrics
Total Assets
83.5B
Total Liabilities
30.9B
Shareholders Equity
52.5B
Debt to Equity
0.59
Cash Flow Metrics
Operating Cash Flow
2.0B
Free Cash Flow
1.7B
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Danaher Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 24.6B | 23.9B | 23.9B | 26.6B | 24.8B |
| Cost of Goods Sold | 10.0B | 9.7B | 9.9B | 10.5B | 9.6B |
| Gross Profit | 14.5B | 14.2B | 14.0B | 16.2B | 15.2B |
| Gross Margin % | 59.1% | 59.5% | 58.7% | 60.8% | 61.4% |
| Operating Expenses | |||||
| Research & Development | 1.6B | 1.6B | 1.5B | 1.5B | 1.5B |
| Selling, General & Administrative | 8.2B | 7.8B | 7.3B | 7.1B | 6.8B |
| Other Operating Expenses | - | - | - | - | 547.0M |
| Total Operating Expenses | 9.8B | 9.3B | 8.8B | 8.7B | 8.9B |
| Operating Income | 4.7B | 4.9B | 5.3B | 7.5B | 6.4B |
| Operating Margin % | 19.1% | 20.4% | 22.1% | 28.3% | 25.8% |
| Non-Operating Items | |||||
| Interest Income | 30.0M | 117.0M | 303.0M | 41.0M | 11.0M |
| Interest Expense | 265.0M | 278.0M | 286.0M | 204.0M | 231.0M |
| Other Non-Operating Income | -222.0M | -56.0M | -252.0M | -227.0M | 344.0M |
| Pre-tax Income | 4.2B | 4.6B | 5.0B | 7.1B | 6.5B |
| Income Tax | 633.0M | 747.0M | 823.0M | 818.0M | 1.1B |
| Effective Tax Rate % | 15.0% | 16.1% | 16.3% | 11.4% | 16.3% |
| Net Income | 3.6B | 3.9B | 4.8B | 7.2B | 6.4B |
| Net Margin % | 14.7% | 16.3% | 19.9% | 27.1% | 25.9% |
| Key Metrics | |||||
| EBITDA | 7.2B | 7.3B | 7.8B | 9.8B | 8.5B |
| EPS (Basic) | $5.07 | $5.33 | $6.44 | $9.80 | $8.77 |
| EPS (Diluted) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 |
| Basic Shares Outstanding | 712700000 | 731000000 | 736500000 | 725100000 | 714600000 |
| Diluted Shares Outstanding | 712700000 | 731000000 | 736500000 | 725100000 | 714600000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Danaher Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 4.6B | 2.1B | 5.9B | 6.0B | 2.6B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 3.9B | 3.5B | 3.9B | 4.1B | 4.6B |
| Inventory | 2.5B | 2.3B | 2.6B | 2.8B | 2.8B |
| Other Current Assets | 1.7B | 1.6B | 1.6B | 1.7B | 1.7B |
| Total Current Assets | 12.8B | 9.5B | 13.9B | 15.9B | 11.6B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.1B | 1.9B | 1.8B | 1.7B | 1.8B |
| Goodwill | 104.1B | 99.6B | 104.0B | 94.4B | 105.2B |
| Intangible Assets | 17.8B | 18.6B | 20.7B | 19.8B | 22.8B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 4.2B | 4.0B | 3.6B | 7.7B | 3.7B |
| Total Non-Current Assets | 70.7B | 68.0B | 70.6B | 68.5B | 71.5B |
| Total Assets | 83.5B | 77.5B | 84.5B | 84.4B | 83.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.8B | 1.8B | 1.8B | 1.9B | 2.6B |
| Short-term Debt | 201.0M | 678.0M | 1.9B | 758.0M | 215.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.4B | 1.1B | 1.2B | 2.2B | 1.3B |
| Total Current Liabilities | 6.8B | 6.8B | 8.3B | 8.4B | 8.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 19.5B | 16.5B | 17.7B | 19.9B | 23.1B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 184.0M | 214.0M | 228.0M | 261.0M | 219.0M |
| Total Non-Current Liabilities | 24.1B | 21.2B | 22.7B | 25.9B | 29.9B |
| Total Liabilities | 30.9B | 28.0B | 31.0B | 34.3B | 38.0B |
| Equity | |||||
| Common Stock | 9.0M | 9.0M | 9.0M | 9.0M | 9.0M |
| Retained Earnings | 46.9B | 44.2B | 41.1B | 39.2B | 32.8B |
| Treasury Stock | 11.4B | 8.2B | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 52.5B | 49.6B | 53.5B | 50.1B | 45.2B |
| Key Metrics | |||||
| Total Debt | 19.7B | 17.1B | 19.5B | 20.6B | 23.3B |
| Working Capital | 5.9B | 2.7B | 5.7B | 7.5B | 3.5B |
Balance Sheet Composition
Danaher Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 3.6B | 3.9B | 4.2B | 6.3B | 5.4B |
| Depreciation & Amortization | 2.4B | 2.4B | 2.2B | 2.1B | 2.1B |
| Stock-Based Compensation | 298.0M | 288.0M | 306.0M | 295.0M | 184.0M |
| Working Capital Changes | -705.0M | 14.0M | -846.0M | -1.4B | -642.0M |
| Operating Cash Flow | 5.6B | 6.6B | 5.9B | 7.3B | 7.7B |
| Investing Activities | |||||
| Capital Expenditures | -1.1B | -1.4B | -1.4B | -1.1B | -1.2B |
| Acquisitions | 9.0M | -558.0M | -5.6B | -582.0M | -10.9B |
| Investment Purchases | -127.0M | -331.0M | -172.0M | -523.0M | -925.0M |
| Investment Sales | 12.0M | 253.0M | 61.0M | 18.0M | 126.0M |
| Investing Cash Flow | -1.2B | -2.0B | -7.0B | -2.1B | -12.9B |
| Financing Activities | |||||
| Share Repurchases | -3.1B | -6.0B | 0 | 0 | 0 |
| Dividends Paid | -878.0M | -768.0M | -1.2B | -818.0M | -742.0M |
| Debt Issuance | 1.6B | - | 0 | 0 | 984.0M |
| Debt Repayment | -500.0M | -1.7B | -620.0M | -965.0M | -1.3B |
| Financing Cash Flow | -3.0B | -8.4B | -273.0M | -2.6B | 1.3B |
| Free Cash Flow | 5.3B | 5.3B | 5.8B | 7.4B | 7.1B |
| Net Change in Cash | 1.5B | -3.8B | -1.5B | 2.6B | -3.9B |
Cash Flow Trend
Danaher Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
34.61
Forward P/E
19.64
Price to Book
2.40
Price to Sales
5.10
PEG Ratio
3.84
Profitability Ratios
Profit Margin
14.89%
Operating Margin
22.94%
Return on Equity
7.08%
Return on Assets
4.19%
Financial Health
Current Ratio
1.87
Debt to Equity
37.17
Beta
0.99
Per Share Data
EPS (TTM)
$5.16
Book Value per Share
$74.32
Revenue per Share
$34.87
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| DHR | 126.4B | 34.61 | 2.40 | 7.08% | 14.89% | 37.17 |
| Thermo Fisher | 174.6B | 25.84 | 3.31 | 13.52% | 15.15% | 82.91 |
| Idexx Laboratories | 44.7B | 42.92 | 27.85 | 66.20% | 24.62% | 60.83 |
| Agilent Technologies | 32.7B | 25.67 | 4.76 | 19.95% | 18.26% | 51.39 |
| Waters | 30.5B | 28.90 | 7.24 | 29.28% | 20.30% | 60.28 |
| Natera | 27.4B | - | 15.75 | -14.32% | -9.03% | 12.52 |
Financial data is updated regularly. All figures are in the company's reporting currency.






